This HTML5 document contains 127 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34104397
rdf:type
wikibase:Item
schema:description
২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artículu científicu espublizáu en 2010 2010年论文 vedecký článok 2010年の論文 мақолаи илмӣ artigo científico (publicado na 2010) artikull shkencor vetenskaplig artikel مقالة علمية наукова стаття, опублікована в березні 2010 2010年論文 мақолаи илмӣ სამეცნიერო სტატია научна статия naučni članak artigo científico научни чланак scientific article 2010年论文 videnskabelig artikel (udgivet 2010) article scientific 2010年论文 articol științific article scientifique (publié 2010) سائنسی مضمون artículo científico publicado en 2010 bilimsel makale 2010년 논문 2010 nî lūn-bûn artigo científico (publicado na 2010) article científic vědecký článek wissenschaftlicher Artikel tudományos cikk 2010年論文 bài báo khoa học tieteellinen artikkeli научни чланак บทความทางวิทยาศาสตร์ 2010年論文 מאמר מדעי 2010年论文 scienca artikolo teaduslik artikkel 2010 թվականի մարտին հրատարակված գիտական հոդված vitskapeleg artikkel artikulong pang-agham mokslinis straipsnis επιστημονικό άρθρο 2010年论文 2010年論文 articolo scientifico научная статья 2010年論文 2010年论文 مقالهٔ علمی 2010 թուականի Մարտին հրատարակուած գիտական յօդուած artykuł naukowy vitenskapelig artikkel wetenschappelijk artikel
p:P577
wds:Q34104397-AFF8CADC-6E9D-42DE-96A6-F81D6531CF82
wdt:P577
2010-03-16T00:00:00Z
p:P2093
wds:Q34104397-22C57B7E-35BB-43C5-8E0D-CB0161D873FE wds:Q34104397-5A40B884-01CA-4B17-86E1-BBD94FED6AF7 wds:Q34104397-8335E15C-4035-4B25-AE95-ED9328DEB523 wds:Q34104397-9F78EFDE-70DE-4D37-BAC8-9F273F05BDE6 wds:Q34104397-DA6FE22B-9999-4D69-84E9-DCD15141C7D5 wds:Q34104397-E5E08813-0B08-48C7-9BF6-1A489071BF0F wds:Q34104397-C28C32B8-AE10-4B20-8034-7579D1716A76
wdt:P2093
Frances Lynn Elizabeth Fisher SENTINEL Investigators Fred D Lublin Daniel R Wynn Christian Confavreux William H Stuart
rdfs:label
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis
skos:prefLabel
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis
schema:name
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis
p:P50
wds:Q34104397-F6409195-0784-4D14-97EC-F43933863635 wds:Q34104397-FDE77E3C-3D8B-4017-A1B4-CEA3652EA8AF wds:Q34104397-3D1B5058-205A-4542-9403-0C44D9D189D6 wds:Q34104397-4EBCDD2F-E04D-47CE-8E89-34F4161EC0CB wds:Q34104397-92D24F96-2806-4BF4-A6AA-31CCC27AE4F8 wds:Q34104397-A1564B1B-082D-47A2-8466-D851757907D6 wds:Q34104397-5DF88580-1D6B-49BB-BE75-97910F664FA2 wds:Q34104397-6F6BF990-6233-41B1-A984-A718DAA1CF17 wds:Q34104397-8974A8CB-3973-4E1C-A77D-8E8F3D549142
wdt:P50
wd:Q125267376 wd:Q125266610 wd:Q37829825 wd:Q43731286 wd:Q64857220 wd:Q125266857 wd:Q7173149 wd:Q114301063 wd:Q41674629
p:P1476
wds:Q34104397-94DC4E23-B64F-41F1-AC66-EAC4FB22CBCD
wdt:P1476
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis
p:P304
wds:Q34104397-85C1A332-0296-4B55-A032-E365C439F60D
wdt:P304
28-35
p:P31
wds:Q34104397-62E71FA3-DE39-4CDD-ABE5-7653FF80F989
wdt:P31
wd:Q13442814
p:P921
wds:Q34104397-8B1D5830-F1EB-4112-855F-9DEDF4513185
wdt:P921
wd:Q8277
p:P698
wds:Q34104397-8DC30AFD-55D3-4B84-A368-140BA983D2B8
wdtn:P698
n12:20236661
wdt:P698
20236661
p:P1433
wds:Q34104397-92B42409-7C19-48BE-B097-10EFC3681E39
wdt:P1433
wd:Q6296168
p:P433
wds:Q34104397-EFF59C9A-A393-4CFE-89D9-15E6AAC22F6C
p:P478
wds:Q34104397-509DD5ED-2399-494C-A488-60699551F601
wdt:P433
1-2
wdt:P478
292
p:P1104
wds:Q34104397-D244CB27-270D-4EAC-A59C-E7C6505F8B74
wdt:P1104
8
p:P356
wds:Q34104397-AE7A8A05-8BB6-4C1E-B925-C630B6022FE6
wdtn:P356
n11:J.JNS.2010.02.012
wdt:P356
10.1016/J.JNS.2010.02.012